IREN IREN
- Market cap
- $9.8B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 13.9×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $707M
- +41% on a year ago
- Net margin
- −99.4%
- Free cash flow yield
- −9.1%
IREN trades at 13.9× sales. Its trailing earnings are negative, so it has no PE. Revenue was $707M over the last twelve months, up 41% on a year earlier with a −99% net margin.
Charts
Financials
| Income statement | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| $52.8M | $116.1M | $144.8M | $187.3M | $240.3M+355% | $184.7M+59% | $144.8M+0% | $137.2M−27% | |
| Cost of revenue | $31.9M | $32.3M | $42M | $52.9M | $80.7M+153% | $65.8M+104% | $39.9M−5% | $33.3M−37% |
| Gross profit | $20.9M | $83.8M | $102.9M | $134.4M | $159.6M+664% | $118.9M+42% | $104.9M+2% | $103.9M−23% |
| SG&A | $25.2M | $28.9M | $29.1M | $53.3M | $138.4M+450% | $100.8M+249% | $81.8M+181% | $128.3M+141% |
| −$47.1M | $17.3M | $29.2M | $17.9M | −$76.4M+62% | −$116.4M | −$233.5M | −$620.4M | |
| Interest expense | $22K | $1.7M | $4.1M | $5.2M | $9.3M+42082% | $10.7M+520% | $14.8M+260% | $24.5M+372% |
| Pre-tax income | −$50.4M | −$18.9M | −$11.1M | $173.9M | $575.3M | −$337.9M+1690% | −$254.1M+2188% | −$692M |
| $1.3M | $3M | $5M | −$2.8M | $190.7M+14774% | −$182.5M | −$6.3M | −$8M+188% | |
| Net income | −$51.7M | −$21.9M | −$16.1M | $176.7M | $384.6M | −$155.4M+610% | −$247.8M+1435% | −$684M |
| −$0.27 | −$0.10 | −$0.07 | $0.71 | $1.08 | −$0.52+420% | −$0.74+957% | −$1.88 | |
| 189.3M | 210.5M | 218.7M | 249M | 361.7M+91% | 298M+42% | 333.7M+53% | 363.6M+46% |
Gross profit: 7 periods, Q1 FY25 to Q4 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: Q4 FY25 and Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY25: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. Q4 FY26: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial - Credit Services nearest IREN's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| IRENIREN | $9.8B | n/m | 86.1× | 13.9× | +41% | −99.4% | |
| HQYHealthequity | $8.6B | 37.7× | 78.2× | 6.3× | +7% | 17.4% | |
| ETSYEtsy | $8B | 53.3× | 50.6× | 2.8× | +4% | 7.3% | |
| ZGZillow | $7.7B | 155× | 154× | 2.7× | +18% | 2.0% | |
| CARTMaplebear | $13.1B | 31.0× | 25.9× | 3.3× | +13% | 12.0% | |
| CSGPCostar | $13.7B | 179× | 91.9× | 3.9× | +22% | 2.1% | |
| WEXWEX | $6.7B | 19.7× | 42.8× | 2.4× | +7% | 12.6% | |
| EXLSExlService | $6.4B | 26.6× | 34.7× | 2.9× | +14% | 11.2% | |
| OMFOneMain | $6.4B | 8.4× | 9.1× | 1.3× | +8% | 15.4% | |
| RBARB Global | $15.6B | 36.1× | 41.8× | 3.2× | +10% | 10.0% | |
| CACCCredit Acceptance | $5.7B | 12.0× | 14.0× | 2.4× | +3% | 21.5% | |
| Peer median | $7.8B | 33.6× | 42.3× | 2.8× | +9% | 11.6% |
Investors who own it
Investors we follow who held IREN at the end of Jun 30, 2026, from their 13F filings.
- Stanley DruckenmillerDuquesne Family Office0.1% of portfolionew
- Baillie GiffordBaillie Gifford0.0% of portfoliotrimmed
More on IREN
Each number over time
Its groups
About
- Industry
- Financial - Credit Services
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .